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Very Important Paper
Tuning Enzyme Activity for Nonaqueous Solvents:
Engineering an Enantioselective “Michaelase” for Catalysis
in High Concentrations of Ethanol
Chao Guo+,[a] Lieuwe Biewenga+,[a] Max Lubberink,[a, b] Ronald van Merkerk,[a] and
Gerrit J. Poelarends*[a]
Introduction
The enzyme 4-oxalocrotonate tautomerase (4-OT) from Pseudo-
monas putida mt-2 catalyzes the tautomerization of 2-hydroxy-
hexa-2,4-dienedioate (1) to 2-oxohex-3-enedioate (2) as part of
a metabolic pathway for the degradation of aromatic hydrocar-
bons (Scheme 1 A).[1, 2] In addition, 4-OT can promiscuously cat-
alyze several C@C bond-forming reactions, including Michael-
type additions and aldol condensations, yielding precursors for
important classes of pharmaceuticals.[3–7] For instance, the 4-OT
catalyzed Michael-type addition of acetaldehyde (3) to nitro-
alkenes 4 a and 4 b yields g-nitroaldehydes 5 a and 5 b, impor-
tant precursors for the g-aminobutyric acid analogues pheni-
but (R-6 a) and pregabalin (S-6 b), respectively (Scheme 1 B).[5]
Hence, several enzyme engineering studies have been per-
formed to improve the activity and enantioselectivity of 4-OT
for this reaction.[8, 9]
Solubilization of substrates 4 a and 4 b requires the use of
cosolvents. Because enzymes have evolved to function under
aqueous conditions, high concentrations of cosolvents can
significantly affect their catalytic performance and eventually
result in enzyme precipitation.[10] In this study, we used a col-
lection of nearly all single-mutant variants of 4-OT to investi-
gate the effect of each mutation on the ability of the enzyme
to retain its “Michaelase” activity in elevated concentrations of
Enzymes have evolved to function under aqueous conditions
and may not exhibit features essential for biocatalytic applica-
tion, such as the ability to function in high concentrations of
an organic solvent. Consequently, protein engineering is often
required to tune an enzyme for catalysis in non-aqueous
solvents. In this study, we have used a collection of nearly all
single mutants of 4-oxalocrotonate tautomerase, which pro-
miscuously catalyzes synthetically useful Michael-type addi-
tions of acetaldehyde to various nitroolefins, to investigate the
effect of each mutation on the ability of this enzyme to retain
its “Michaelase” activity in elevated concentrations of ethanol.
Examination of this mutability landscape allowed the identifi-
cation of two hotspot positions, Ser30 and Ala33, at which
mutations are beneficial for catalysis in high ethanol concen-
trations. The “hotspot” position Ala33 was then randomized in
a highly enantioselective, but ethanol-sensitive 4-OT variant
(L8F/M45Y/F50A) to generate an improved enzyme variant
(L8F/A33I/M45Y/F50A) that showed great ethanol stability and
efficiently catalyzes the enantioselective addition of acetalde-
hyde to nitrostyrene in 40 % ethanol (permitting high substrate
loading) to give the desired g-nitroaldehyde product in excel-
lent isolated yield (89 %) and enantiopurity (ee = 98 %). The pre-
sented work demonstrates the power of mutability-landscape-
guided enzyme engineering for efficient biocatalysis in non-
aqueous solvents.
Scheme 1. A) Tautomerization reaction naturally catalyzed by 4-OT. B) Mi-
chael-type addition of acetaldehyde (3) to nitroalkenes 4 a and 4 b, promis-
cuously catalyzed by 4-OT. Products 5 a and 5 b are precursors for phenibut
((R)-6 a) and pregabalin ((S)-6 b), respectively.
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ethanol. Ethanol was selected as cosolvent because it is readily
accessible from bio-renewable sources and can also function
as a precursor for 3.[11] Randomization of the identified “hot-
spot” position Ala33 in the context of a previously engineered
highly enantioselective, but ethanol-sensitive, 4-OT variant
(L8F/M45Y/F50A) afforded an improved enzyme variant (4-OT
L8F/A33I/M45Y/F50A) with high ethanol stability, allowing effi-
cient and enantioselective Michael-type addition reactions in
40 % (v/v) ethanol. As such, our work provides an interesting
example of how targeted mutagenesis of a single amino acid
can radically modify the cosolvent stability of an enzyme, al-
lowing efficient catalysis in high concentrations of ethanol.
Results
In order to identify “hotspot” positions of 4-OT at which muta-
tions are beneficial for catalysis in high concentrations of
ethanol, a defined collection of 1040 single-mutant variants of
4-OT[8] was screened using cell-free extracts (CFEs) prepared
from cultures each expressing a different 4-OT mutant. The Mi-
chael-type addition of 3 to 4 a was used as a model reaction in
screening owing to the marked absorbance of 4 a at 320 nm.
Control experiments demonstrated no significant difference
between the effect of ethanol on the reaction catalyzed by pu-
rified 4-OT or 4-OT present in CFE (Figure S1). The “Michaelase”
activity of each single-mutant variant of 4-OT was measured
using either 5 or 25 % ethanol as cosolvent and the remaining
activity at 25 % ethanol, compared to that at 5 % ethanol, was
graphically represented in a mutability landscape for solvent
tolerance (Figure 1). Increasing the concentration of ethanol
from 5 to 25 % reduced the “Michaelase” activity of wild-type
4-OT by approximately 50 % (Figures 1 and 2 A). Interestingly,
analysis of the ethanol-tolerance mutability landscape revealed
two “hotspot” positions, Ser30 and Ala33, at which single mu-
tations resulted in enzyme variants that showed more than
70 % residual “Michaelase” activity at 25 % ethanol (Figure 1).
Notably, the crystal structure of wild-type 4-OT does not pro-
vide an immediate explanation for the improved ethanol toler-
ance caused by mutations at these two positions (Figure S2),
illustrating the importance of mutability-landscape navigation
to identify functional “hotspot” positions. Three single mutants,
4-OT S30C, S30Y and A33D, which showed high ethanol toler-
ance, were purified and the effect of ethanol and other cosol-
vents on the “Michaelase” activity was tested (Figure 2). Inter-
estingly, 4-OT S30C, S30Y and A33D also showed tolerance to-
wards other cosolvents such as DMSO and isopropanol, sug-
gesting that these mutations convey general cosolvent resist-
ance. Notably, while the 4-OT variants perform well up to 40 %
DMSO, visible protein precipitation with concomitant loss of
activity was observed at DMSO concentrations +50 % (v/v).
We next investigated if we could use the information from
the solvent-tolerance mutability landscape to engineer a previ-
ously constructed highly enantioselective 4-OT variant, L8F/
M45Y/F50A (4-OT FYA),[9] to function in high concentrations of
ethanol. As single mutants at “hotspot” position Ala33 general-
ly exhibited higher “Michaelase” activity than those at “hot-
spot” position Ser30, we focused our mutagenesis strategy on
position Ala33.[8] In the context of 4-OT FYA, residue Ala33 was
mutated to all possible amino acids and the nineteen enzyme
variants were expressed and purified to homogeneity. Initially,
we tested all variants for visible precipitation upon incubation
(1 h) of the enzyme with increasing concentrations of ethanol
(up to 50 %). The parental enzyme 4-OT FYA rapidly precipitat-
ed when incubated with ethanol concentrations equal to or
greater than 10 % (Figure 3 D). Interestingly, enzyme variants
with isoleucine (A33I/FYA), leucine (A33L/FYA) or valine (A33V/
FYA) at position 33 could tolerate up to 50 % ethanol without
any visible protein precipitation after 1 hour of incubation. No-
tably, substitution of Ala33 to aspartate, glutamate or cysteine
in the context of 4-OT FYA also strongly improved the stability
of the enzyme in high concentrations of ethanol, tolerating up
to 40 % ethanol without visible protein precipitation.
Figure 1. Ethanol-tolerance mutability landscape of 4-OT. The horizontal axis of the data matrix represents the residue positions of 4-OT. The vertical axis rep-
resents all 20 canonical amino acids. The wild-type amino acid at each position is indicated with a bold square. White squares indicate that this mutant is not
present in the collection. The color of the square indicates the residual “Michaelase” activity of a specific single-mutant variant of 4-OT for the addition of 3
to 4 a in 25 % ethanol, compared to that in 5 % ethanol. Grey boxes indicate that the “Michaelase” activity was too low to determine the remaining activity.




Next, we tested the activity and enantioselectivity of these
six quadruple mutants in the presence of 5, 30 or 50 % ethanol.
The Michael-type addition of 3 to 4 b was used as model re-
action because the optical purity of product 5 b can easily be
analyzed by gas chromatography. All six quadruple mutants
proved to be highly enantioselective giving nearly enantiopure
product 5 b, and, importantly, increasing ethanol concentra-
tions do not negatively affect enzyme enantioselectivity
(Table 1). In the presence of 30 % ethanol, the reactions with
the six quadruple mutants were completed within 35–70 min,
whereas the reaction with the parental enzyme (4-OT FYA)
showed no conversion due to rapid protein precipitation
(Table 1).
The best mutant, 4-OT A33I/FYA, catalyzed the Michael-type
addition reaction practically as efficient in 40 % ethanol as in
10 % ethanol (Figure 3 B). Moreover, pre-incubation of 4-OT
A33I/FYA in 50 % ethanol for 10 h resulted in only 25 % loss of
activity (Figure 3 A). On the contrary, the parental enzyme (4-
OT FYA) rapidly lost its activity upon incubation in 10 % etha-
nol (Figure 3 A, B). Interestingly, an increase in the T 6050 of ap-
proximately 6 8C was observed for 4-OT A33I/FYA compared to
4-OT FYA, indicating that 4-OT A33I/FYA is also somewhat
more thermostable than 4-OT FYA (Figure 3 C). Finally, to fur-
ther demonstrate the synthetic usefulness of 4-OT A33I/FYA, a
semi-preparative scale reaction was performed, using 40 %
ethanol as cosolvent, which allowed for the solubilization of
15 mm 4 a. Using a 6.7-fold excess of 3 over 4 a, the reaction
was finished within 200 min. Product (R)-5 a was obtained in
excellent isolated yield (89 %) and enantiopurity (ee = 98 %; Fig-
ures S3 and S4). Taken together, these results demonstrate that
4-OT can be engineered to efficiently catalyze enantioselective
Michael-type reactions in ethanol concentrations up to 40 %.
Discussion
Enzymes are highly attractive catalysts for organic synthesis
because of their unparalleled enantio-, regio- and chemoselec-
tivity. Given that enzymes have evolved to operate in the mild
aqueous environment of the cell, they are usually not fit for
preparative biocatalysis in the presence of high concentrations
of organic cosolvents required for substrate solubilization.[10] A
solution to this problem is the engineering of enzymes to im-
prove their cosolvent tolerance. Rational enzyme engineering
towards increased cosolvent tolerance is still very challenging
due to our relatively poor understanding of the interactions
between enzymes and solvent molecules.[12–14] Currently em-
ployed rational engineering strategies include stabilization of
flexible regions, introduction of new cysteine bridges and
modification of access tunnels.[14–17]
An important strategy to guide enzyme-engineering efforts
is to make use of mutability landscapes.[18–21] By screening a
large collection of nearly all single mutants of an enzyme, im-
portant information is obtained on single mutations or residue
positions that influence a desired characteristic of the enzyme.
Here we have applied mutability-landscape-guided enzyme en-
gineering to improve the ethanol tolerance of 4-OT. Screening
of a collection of nearly all single-mutant variants of 4-OT re-
vealed that mutations at particularly positions Ser30 and Ala33
resulted in improved ethanol tolerance. Interestingly, a previ-
ously reported 4-OT variant with 3.5-fold increased “Michae-
Figure 2. Michael-type addition of 3 to 4 a catalyzed by purified wild-type 4-OT or 4-OT mutants in the presence of different cosolvent concentrations. A) eth-
anol, B) methanol, C) propane-1,3-diol, D) DMSO, E) isopropanol, F) tert-butanol. The activity of each mutant is normalized to the activity in the presence of
5 % cosolvent.




lase” activity, 4-OT A33D, also showed improved ethanol toler-
ance.[8] We used the information from the ethanol-tolerance
mutability landscape to further engineer a previously con-
structed highly enantioselective 4-OT variant (FYA) that exhibits
poor ethanol stability. All 19 possible variants at position Ala33
in the context of 4-OT FYA were constructed, expressed and
purified. Remarkably, from this small, focused set of quadruple
mutants, six mutants showed strongly improved ethanol toler-
ance. It is interesting to note that all six variants, including 4-
OT A33D/FYA, are highly enantioselective towards the synthe-
Figure 3. Characterization of 4-OT A33I/FYA (FIYA). A) Enzyme activity for the Michael-type addition of 3 to 4 a after pre-incubation (1, 2, 4, 6, 8 or 10 h) in the
presence of 10, 30 or 50 % ethanol. The data is normalized to the activity of the enzyme without pre-incubation. B) Progress curves of 4-OT A33I/FYA- and 4-
OT FYA-catalyzed Michael-type additions in the presence of different ethanol concentrations. C) Temperature-induced inactivation profiles of 4-OT A33I/FYA
and 4-OT FYA. The enzyme activity after incubation for 60 min at 30 8C was set as 100 %. D) Photograph of cuvettes in which 4-OT FYA (190 mg mL@1, top five
cuvettes) and 4-OT A33I/FYA (190 mg mL@1, bottom five cuvettes) were incubated for 1 h in 20 mm NaH2PO4 buffer (pH 7.3) containing 10, 20, 30, 40 or 50 %
(v/v) ethanol (cuvette 1 to 5, respectively, from left to right). 4-OT FYA shows rapid precipitation in buffer containing >10 % ethanol.
Table 1. Biocatalytic addition of 3 to 4 b catalyzed by 4-OT mutants in different ethanol concentrations.[a]
Enzyme 5 % v/v ethanol 30 % v/v ethanol 50 % v/v ethanol
ee[b] Reaction time [min][c] ee[b] Reaction time [min][c] ee[b] Reaction time [min][c]
FYA 98 (S) 40 –[d] –[d] –[d] –[d]
A33D/FYA 98 (S) 50 98 (S) 70 92 (S) >360[e]
A33E/FYA 96 (S) 30 96 (S) 60 98 (S) >360[e]
A33C/FYA 98 (S) 55 98 (S) 70 –[d] –[d]
A33I/FYA 98 (S) 30 98 (S) 35 98 (S) 90
A33L/FYA 98 (S) 35 98 (S) 50 96 (S) 180
A33V/FYA 98 (S) 35 98 (S) 45 98 (S) 120
[a] Assay conditions: 3 mm 4 b, 100 mm 3, 73 mm 4-OT, 20 mm NaH2PO4 (pH 7.3), 0.3 mL reaction volume. [b] Determined by GC using a chiral stationary
phase; the absolute configuration was determined by literature comparison.[8, 9] [c] Reaction progress was monitored by following the depletion in absorb-
ance at 249 nm. [d] No data due to protein precipitation. [e] Reaction was not finished after 360 min.




sis of (S)-5 b, similar to the parental mutant 4-OT FYA.[9] Con-
versely, the single mutant 4-OT A33D markedly improved the
enantioselectivity towards the opposite enantiomer (R)-5 b.[8]
Incubation of the best mutant, 4-OT A33I/FYA, for 10 h in
the presence of 50 % ethanol resulted in only 25 % loss of ac-
tivity, whereas the parental enzyme 4-OT FYA lost all its activity
upon incubation for 1 h in 10 % ethanol. 4-OT A33I/FYA also
showed an increase in thermostability compared to 4-OT FYA,
an effect that has also been observed for other enzymes that
have been engineered towards increased solvent toler-
ance.[22, 23] We further show that 4-OT A33I/FYA can be used to
efficiently catalyze the Michael-type addition of 3 to 4 a in the
presence of 40 % ethanol, which permitted the use of a higher
substrate loading (up to 15 mm 4 a). Product (R)-5 a could be
obtained in good isolated yield (89 %) and with excellent enan-
tiopurity (ee = 98 %).
Conclusion
In summary, our results demonstrate the power of mutability
landscapes to guide engineering efforts to improve the cosol-
vent tolerance of enzymes. By specifically targeting the identi-
fied “hotspot” position Ala33, we could engineer an ethanol-
sensitive mutant, 4-OT FYA, into a highly ethanol-resistant
mutant 4-OT A33I/FYA. Further tuning of 4-OT A33I/FYA might
lead to new synthetic opportunities in almost neat organic sol-
vents.
Experimental Section
Production of cell-free extract : Cell-free extracts (CFE) of 4-OT
single mutants were prepared according to a reported proce-
dure.[8]
Construction of the ethanol-tolerance mutability landscape : The
CFEs prepared from cells producing 4-OT single-mutant variants
were used in two reactions, containing either 5 % or 25 % v/v etha-
nol. The following reaction conditions were used: CFE (20 % v/v), 3
(50 mm), 4 a (0.5 mm) in 20 mm NaH2PO4 buffer (pH 7.3), 100 mL
final volume. The reactions were performed in 96-well microtiter
plates (MTP; UV-star mclear, Greiner Bio-one), covered with UV-
transparent plate seals (VIEWsealTM, Greiner Bio-one). To ensure
proper mixing of the reagents, the plate was shaken (60 s at
500 rpm) immediately after all reaction components were added.
The reaction progress was monitored in a plate reader by measur-
ing the depletion in absorbance at 320 nm, corresponding to the
concentration of 4 a, for 60 min with a 60 s data interval. The slope
of the linear part of the curve was determined for both the re-
actions. The remaining enzymatic activity was determined by divid-
ing the slope of the reaction in 25 % v/v ethanol by the slope of
the reaction in 5 % v/v ethanol.
4-OT purification : The purification of 4-OT single mutants[24] and 4-
OT quadruple mutants[9] are based on previously reported proce-
dures. All purified proteins were >90 % pure as assessed by SDS-
PAGE. All purified mutants were analyzed by electron spray ioniza-
tion (ESI) mass spectrometry to confirm the correct mass of the
enzyme. The purified protein was flash-frozen in liquid nitrogen
and stored at @80 8C until further use.
UV-spectroscopic assay for the enzymatic activity of 4-OT single
mutants in different organic solvents : The enzymatic activities of
the 4-OT mutants and wild-type 4-OT was monitored by following
the decrease in absorbance at 320 nm, which corresponds to the
depletion of 4 a. Purified enzyme (150 mg, 73 mm) was incubated in
a 1 mm cuvette with 3 (50 mm) and 4 a (2 mm) in 20 mm NaH2PO4
(pH 7.3; 0.3 mL final volume).
Construction of 19 Ala33 mutants of 4-OT L8F/M45Y/F50A :
Ala33 was randomized by Quikchange technology using the gene
encoding 4-OT L8F/M45Y/F50A cloned in the pET20b vector as the
template. The following two primers were used: 5’-GCTCCCTGGAT-
NNKCCGCTGACCAG-3’ and 5’-CTGGTCAGCGGMNNATCCAGGGAGC-
3’. After transformation of the DNA into Escherichia coli cells,
random colonies were picked from an agar plate, and the mutant
4-OT genes were sequenced by Macrogen Europe (Meibergdreef
31, 1105AZ, Amsterdam, the Netherlands) until all of the 19 quad-
ruple mutants were obtained.
Activity assays of the six best quadruple mutants : The enzymatic
activities of the 4-OT quadruple mutants and 4-OT L8F/M45Y/F50A
were monitored by following the decrease in absorbance at
249 nm, which corresponds to the depletion of 4 b. Purified
enzyme (150 mg, 73 mm) was incubated in a 1 mm cuvette with 3
(100 mm) and 4 b (3 mm) in 20 mm NaH2PO4 buffer (pH 7.3; 0.3 mL
final volume). After the reactions were completed, product 5 b was
extracted with ethyl acetate (400 mL) and analyzed by gas chroma-
tography using an Astec CHIRALDEX G-TA column, isocratic 125 8C.
Retention time (S)-5 b : 25.6 min, retention time R-5 b : 26.9. The
assignment of the absolute configuration was based on earlier
reported data.[9]
Determination of T6050: 4-OT L8F/M45Y/F50A and 4-OT L8F/A33I/
M45Y/F50A (50 mL of 2 mg mL@1 in 20 mm NaH2PO4, pH 7.3) were
incubated in 0.2 mL PCR tubes at temperatures ranging from 30 to
90 8C for 60 min in a thermal cycler. After incubation, the enzymes
were cooled on ice for 10 min followed by equilibration at 25 8C
for 10 min. Samples were centrifuged to remove any precipitated
protein. The residual “Michaelase” activity for the addition of 3 to
4 a was tested in a plate reader. Following conditions were used:
25 mL of enzyme supernatant, 50 mm 3, 0.5 mm 4 a, 5 % v/v ethanol
in 20 mm NaH2PO4 buffer (pH 7.3), 100 mL final volume. The “Mi-
chaelase” activities were normalized to that obtained after 60 min
incubation at 30 8C.
Stability of 4-OT L8F/M45Y/F50A and 4-OT L8F/A33I/M45Y/F50A
upon incubation with increasing ethanol concentrations : 4-OT
L8F/M45Y/F50A and 4-OT L8F/A33I/M45Y/F50A (1 mL of
1.5 mg mL@1 in 20 mm NaH2PO4, pH 7.3) were incubated in 20 mm
NaH2PO4 buffer (pH 7.3) containing 10, 30 or 50 % v/v ethanol in a
water bath of 25 8C. Aliquots of enzyme (80 mL) were taken at dif-
ferent time intervals and centrifuged to remove any aggregated
protein. 50 mL of the supernatant was used to test the residual en-
zymatic activity. The reaction mixture consisted of the following: 3
(50 mm), 4 a (2 mm, from a 40 mm stock solution in 100 % (v/v)
ethanol) in 20 mm NaH2PO4 buffer (pH 7.3), 0.3 mL final volume.
Depletion of 4 a was monitored by following the decrease in ab-
sorbance at 320 nm in time. The activities were normalized to the
activity measured without incubation of the enzyme.
Semipreparative-scale synthesis : To a 50 mL round bottom flask
was added: 6 mL ethanol, 112 mL 3, 12 mL buffer (20 mm NaH2PO4,
pH 6.5) containing 4-OT L8F/A33I/M45Y/F50A. The reaction was ini-
tiated by the addition of 2 mL ethanol containing 150 mm 4 a. The
final concentrations were: 3 (100 mm), 4 a (15 mm), 4-OT L8F/A33I/
M45Y/F50A (75 mm, based on monomer concentration), and 40 %




(v/v) ethanol in 20 mm NaH2PO4 buffer (pH 6.5). The reaction prog-
ress was monitored using UV-spectrophotometric analysis. At
timely intervals, a sample of 30 mL was collected from the reaction
mixture and diluted to 300 mL with 20 mm NaH2PO4 buffer and a
full spectrum from 200 nm to 500 nm was recorded. After 200 min,
the reaction was finished. The reaction mixture was extracted 3 V
with ethyl acetate. The combined organic layers were washed with
brine and dried over anhydrous Na2SO4. The organic layer was con-
centrated in vacuo, yielding 5 a without any further purification
(51.5 mg, 89 % yield). The aldehyde functionality of 5 a was derivat-
ized to a cyclic acetal according to a reported procedure.[5] The
enantiopurity of derivatized 5 a was determined by reverse phase
HPLC using a Chiralpak AD-RH column (150 mm V 4.6 mm, Daicel)
MeCN/water 70:30. Retention time (R)-5 a : 7.8 min, (S)-5 a :
10.8 min.
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